One hundred and twelve infected arthroplasties treated with 'DAIR' (debridement, antibiotics and implant retention): Antibiotic duration and outcome

Journal of Antimicrobial Chemotherapy

Volumn 63, Issue 6, 2009, Pages 1264-1271

  Byren, Ivor ^a,b   Bejon, P ^a,b   Atkins, B L ^a,b,c   Angus, B ^b   Masters, S ^a   McLardy Smith, P ^a   Gundle, R ^a   Berendt, A ^a  

^a NUFFIELD ORTHOPAEDIC CENTRE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Infection; Management; Prosthetic

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; FUSIDIC ACID; MEROPENEM; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTHROSCOPIC DEBRIDEMENT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIARRHEA; DRUG ERUPTION; DRUG FEVER; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEPATITIS; HUMAN; IMPLANT; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NAUSEA; PROSTHESIS INFECTION; STAPHYLOCOCCUS INFECTION; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ARTHROPLASTY; DEBRIDEMENT; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 65749097225     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp107     Document Type: Article

References (44)

1. Lavernia CJ, Guzman JF, Gachupin-Garcia A. Cost effectiveness and quality of life in knee arthroplasty. Clin Orthop Relat Res 1997; 345: 134-9.
2. Chang RW, Pellisier JM, Hazen GB. A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip. JAMA 1996; 275 858-65.
3. Ethgen O, Bruyere O, Richy F et al. Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature. J Bone Joint Surg Am 2004; 86-A: 963-74.
4. Phillips CB, Barrett JA, Losina E et al. Incidence rates of dislocation, pulmonary embolism, and deep infection during the first six months after elective total hip replacement. J Bone Joint Surg Am 2003; 85-A: 20-6.
5. Kurtz S, Ong K, Lau E et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007; 89: 780-5.
6. Silva M, Tharani R, Schmalzried TP. Results of direct exchange or debridement of the infected total knee arthroplasty. Clin Orthop Relat Res 2002; 404: 125-31.
7. Fisman DN, Reilly DT, Karchmer AW et al. Clinical effectiveness and cost-effectiveness of 2 management strategies for infected total hip arthroplasty in the elderly. Clin Infect Dis 2001; 32: 419-30.
8. Tshefu K, Zimmerli W, Waldvogel FA. Short-term administration of rifampin in the prevention or eradication of infection due to foreign bodies. Rev Infect Dis 1983; 5 Suppl 3: S474-80.
9. Zimmerli W, Frei R, Widmer AF et al. Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J Antimicrob Chemother 1994; 33: 959-67.
10. Barberan J, Aguilar L, Carroquino G et al. Conservative treatment of staphylococcal prosthetic joint infections in elderly patients. Am J Med 2006; 119: 993.e7-10.
11. Zimmerli W, Widmer AF, Blatter M et al. Role of rifampicin for treatment of orthopedic implant-related staphylococcal infections: A randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 1998; 279: 1537-41.
12. Soriano A, Garcia S, Bori G et al. Treatment of acute post-surgical infection of joint arthroplasty. Clin Microbiol Infect 2006; 12: 930-3.
13. Drancourt M, Stein A, Argenson JN et al. Oral rifampicin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrob Agents Chemother 1993; 37: 1214-8.
14. Tattevin P, Cremieux AC, Pottier P et al. Prosthetic joint infection: When can prosthesis salvage be considered? Clin Infect Dis 1999; 29: 292-5.
15. Laffer RR, Graber P, Ochsner PE et al. Outcome of prosthetic knee-associated infection: Evaluation of 40 consecutive episodes at a single centre. Clin Microbiol Infect 2006; 12: 433-9.
16. Berdal JE, Skramm I, Mowinckel P et al. Use of rifampicin and ciprofloxacin combination therapy after surgical debridement in the treatment of early manifestation prosthetic joint infections. Clin Microbiol Infect 2005; 11: 843-5.
17. Trampuz A, Cattelan C, Fluckiger U et al. Treatment outcome of prosthetic joint infection: Ten year cohort study (1992-2003). In: Abstracts of the Forty-fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 2005. Abstract K-883, p. 322. American Society for Microbiology, Washington, DC, USA.
18. Marculescu CE, Berbari EF, Hanssen AD et al. Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis 2006; 42: 471-8.
19. Berbari EF, Osmon DR, Duffy MC et al. Outcome of prosthetic joint infection in patients with rheumatoid arthritis: The impact of medical and surgical therapy in 200 episodes. Clin Infect Dis 2006; 42 216-23.
20. Crockarell JR, Hanssen AD, Osmon DR et al. Treatment of infection with debridement and retention of the components following hip arthroplasty. J Bone Joint Surg Am 1998; 80: 1306-13.
21. Chiu FY, Chen CM. Surgical debridement and parenteral antibiotics in infected revision total knee arthroplasty. Clin Orthop Relat Res 2007; 461: 130-5.
22. Burger RR, Basch T, Hopson CN. Implant salvage in infected total knee arthroplasty. Clin Orthop Relat Res 1991; 273: 105-12.
23. Rao N, Crossett LS, Sinha RK et al. Long-term suppression of infection in total joint arthroplasty. Clin Orthop Relat Res 2003; 414: 55-60.
24. Brandt CM, Sistrunk WW, Duffy MC et al. Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis 1997; 24: 914-9.
25. Deirmengian C, Greenbaum J, Lotke PA et al. Limited success with open debridement and retention of components in the treatment of acute Staphylococcus aureus infections after total knee arthroplasty. J Arthroplasty 2003; 18: 22-6.
26. Schoifet SD, Morrey BF. Treatment of infection after total knee arthroplasty by debridement with retention of the components. J Bone Joint Surg Am 1990; 72: 1383-90.
27. Mont MA, Waldman B, Banerjee C et al. Multiple irrigation, debridement, and retention of components in infected total knee arthroplasty. J Arthroplasty 1997; 12: 426-33.
28. Teeny SM, Dorr L, Murata G et al. Treatment of infected total knee arthroplasty. Irrigation and debridement versus two-stage reimplantation. J Arthroplasty 1990; 5: 35-9.
29. Aboltins CA, Page MA, Buising KL et al. Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid. Clin Microbiol Infect 2007; 13: 586-91.
30. Segreti J, Nelson JA, Trenholme GM. Prolonged suppressive antibiotic therapy for infected orthopedic prostheses. Clin Infect Dis 1998; 27: 711-3.
31. Waldman BJ, Hostin E, Mont MA et al. Infected total knee arthroplasty treated by arthroscopic irrigation and debridement. J Arthroplasty 2000; 15: 430-6.
32. Dixon P, Parish EN, Cross MJ. Arthroscopic debridement in the treatment of the infected total knee replacement. J Bone Joint Surg Br 2004; 86: 39-42.
33. Choong PF, Dowsey MM, Carr D et al. Risk factors associated with acute hip prosthetic joint infections and outcome of treatment with a rifampin-based regimen. Acta Orthop 2007; 78: 755-65.
34. Widmer AF, Gaechter A, Ochsner PE et al. Antimicrobial treatment of orthopedic implant-related infections with rifampicin combinations. Clin Infect Dis 1992; 14: 1251-3.
35. Ilahi OA, Al-Habbal GA, Bocell JR et al. Arthroscopic debridement of acute periprosthetic septic arthritis of the knee. Arthroscopy 2005; 21: 303-6.
36. Giulieri SG, Graber P, Ochsner PE et al. Management of infection associated with total hip arthroplasty according to a treatment algorithm. Infection 2004; 32: 222-8.
37. Atkins BL, Athanasou N, Deeks JJ et al. Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. The OSIRIS Collaborative Study Group. J Clin Microbiol 1998; 36: 2932-9.
38. Mirra JM, Amstutz HC, Matos M et al. The pathology of the joint tissues and its clinical relevance in prosthesis failure. Clin Orthop Relat Res 1976; 117: 221-40.
39. Feldman DS, Lonner JH, Desai P et al. The role of intraoperative frozen sections in revision total joint arthroplasty. J Bone Joint Surg Am 1995; 77: 1807-13.
40. Moran E, Masters S, Berendt AR et al. Guiding empirical antibiotic therapy in orthopaedics: The microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention. J Infect 2007; 55: 1-7.
41. Matthews PC, Conlon CP, Berendt AR et al. Outpatient parenteral antimicrobial therapy (OPAT): Is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years. J Antimicrob Chemother 2007; 60: 356-62.
42. Schaubel DE. Variance estimation for clustered recurrent event data with a small number of clusters. Stat Med 2005; 24: 3037-51.
43. Durham LK, Longini IM Jr, Halloran ME et al. Estimation of vaccine efficacy in the presence of waning: Application to cholera vaccines. Am J Epidemiol 1998; 147: 948-59.
44. Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg Am 1996; 78: 512-23.